Clinical and community trials
About this study
People with advanced kidney disease or those receiving dialysis often have other diseases related to the heart, brain and blood vessels, known as vascular disease (for example, heart attack, stroke and poor blood circulation). However, few treatments have been proven to prevent these conditions in people with advanced kidney disease. Blood thinners (medicines that prevent blood clots) are frequently used and proven to help other groups of people who are at high risk of vascular disease.
There is little understanding of whether blood thinners provide similar benefits in people with advanced kidney disease. The aim of the TRACK study is to find out whether a low dose of blood thinning medicine can reduce heart and vascular disease better than placebo (a look alike tablet that contains no active medication) in people with advanced kidney disease.
Recruitment criteria
Inclusion:
Age ≥18 years,
Advanced kidney disease (kidney failure on dialysis, or
The CEDAW Index
The United Nations (UN) treaty body system is a powerful mechanism for promoting human rights. The UN influences government action through monitoring, programs, and country-specific recommendations.
In the context of women’s rights, the Committee on the Elimination of All Forms of Discrimination Against Women (CEDAW) influences government action by periodically reviewing 189 countries every four years. Governments report on their progress ahead of each review, and civil society organisations offer grassroots perspectives to the Committee in the form of ‘shadow reports’ which validate or challenge government narratives.
The problem
A significant challenge limiting the potential of the UN treaty body system is that the CEDAW Committee lacks clarity on the implementation of its recommendations, and their overall effectiveness in achieving health and social outcomes.
Despite its 40-year history, CEDAW lacks a systematic monitoring tool to track implementation. Government
Join Us: Strengthening Australia’s research capability
Background
Australia is a world leader in health and medical research, however an ongoing research barrier is the slow recruitment of research participants across the country.
Increasing community involvement in medical research is a key goal for the government’s “National One Stop Shop” for clinical trials.
Research registers are a proven way of connecting patients and researchers, but these registers typically address specific diseases, focus on people attending metropolitan centres of excellence, and can be difficult for patients to navigate.
Disease-agnostic research registers offer participants of all types a single point of access to research.
Aims
Join Us is a not-for-profit, disease-agnostic health research register dedicated to connecting everyday Australians with meaningful research opportunities.
Join Us aims to achieve better health and wellbeing for the Australian community by removing a major barrier to the recruitment of participant
